---
title: "300878.SZ (300878.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300878.SZ/news.md"
symbol: "300878.SZ"
name: "300878.SZ"
parent: "https://longbridge.com/en/quote/300878.SZ.md"
datetime: "2026-05-21T07:06:45.407Z"
locales:
  - [en](https://longbridge.com/en/quote/300878.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300878.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300878.SZ/news.md)
---

# 300878.SZ (300878.SZ) — Related News

### [Four pharmaceutical companies related to centralized procurement have been listed on the violation list](https://longbridge.com/en/news/282006060.md)
*2026-04-08T08:52:21.000Z*
> The National Organization for Drug Procurement Office announced the cancellation of the selected qualification for the m

### [Pharmaceutical stocks surged against the market trend! On September 20, 2023, a "30cm" limit up!](https://longbridge.com/en/news/281465073.md)
*2026-04-02T04:31:25.000Z*
> In today's early trading, the A-shares overall weakened. Driven by a collective surge in pharmaceutical stocks, the Nort

### [The concept of innovative drugs continues to strengthen, Salubris hits the daily limit](https://longbridge.com/en/news/278483963.md)
*2026-03-10T03:20:22.000Z*
> The concept of innovative drugs continues to strengthen, with Salubris hitting the daily limit, and HITECK and WECOME ri

### [](https://longbridge.com/en/news/278483822.md)
*2026-03-10T03:15:17.000Z*
> The A-share innovative drug concept continues to strengthen, with Salubris hitting the daily limit, HITECK and WECOME ri

### [Eight departments issued a heavy document! The Chinese medicine sector exploded, Zhendong Pharmacy surged over 19%, TY PHAR. and Hansen Pharmaceutical hit the daily limit](https://longbridge.com/en/news/275061561.md)
*2026-02-06T02:27:17.000Z*
> The Chinese medicine sector surged against the trend in the morning session, with Zhendong Pharmacy rising over 19%, and

### [YKYY issued a profit warning, expecting a net loss attributable to shareholders of RMB 235 million to RMB 280 million for the year 2025](https://longbridge.com/en/news/274291627.md)
*2026-01-30T10:31:05.000Z*
> YKYY released a notice of expected annual performance loss for 2025, estimating a net profit attributable to the parent 

### [WECOME Pharmaceuticals issued a profit warning, expecting a net loss attributable to the parent company of 170 million to 245 million yuan for the fiscal year 2025](https://longbridge.com/en/news/273667977.md)
*2026-01-26T07:59:29.000Z*
> WECOME expects a net loss attributable to the parent company for the fiscal year 2025 to be between 170 million yuan and

### [WECOME: Obtained the drug registration certificate for Er Dong Tang granules](https://longbridge.com/en/news/273666321.md)
*2026-01-26T07:46:20.000Z*
> WECOME announced that the company recently received the "Drug Registration Certificate" approved and issued by the Natio

### ["A-Share Focus" Innovative drug concept surged in the afternoon, Guangzhou accelerates the strategic layout of innovative drugs](https://longbridge.com/en/news/272029558.md)
*2026-01-09T06:02:00.000Z*
> The innovative drug concept surged in the afternoon, with WECOME and JLPC hitting the daily limit, and Shanghai Yizhong 

### [](https://longbridge.com/en/news/272026270.md)
*2026-01-09T05:26:09.000Z*
> The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SH